Americas Medical Cannabis Market, by Application, 2018-2027

Growth Outlook

• The 2027 portion of the Americas Medical Cannabis Market, by Application, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 20614 Mn in 2026 and is projected to reach USD 22935 Mn by 2027 — a gain of about 11% over the forecast period, translating to a CAGR in the double digits.
• The medical cannabis market in the Americas has seen a significant growth in recent years, with an increasing number of countries legalizing the use of cannabis for medical purposes. The market is being driven by a variety of applications, which are helping to revolutionize the medical industry and provide patients with alternative forms of treatment.
• What the regional split looks like (2026): Pain Management leads, holding roughly 47% of segment value — the single largest regional share. Neurological Health Management is the second-largest contributor. Mental Health Management make up the remainder, in descending order.
• By 2027, Pain Management alone is expected to reach USD 10582 Mn, with Neurological Health Management at USD 7894 Mn.

Market Dynamics

The medical cannabis market in the Americas has seen a significant growth in recent years, with an increasing number of countries legalizing the use of cannabis for medical purposes. The market is being driven by a variety of applications, which are helping to revolutionize the medical industry and provide patients with alternative forms of treatment. One of the key applications of medical cannabis in the Americas is pain management. Chronic pain affects millions of people globally, and traditional forms of treatment such as opioids can be highly addictive and come with a range of negative side effects. Medical cannabis, on the other hand, has been found to be effective in relieving pain without the risk of addiction. This has led to a growing number of patients turning to medical cannabis for pain management, thus driving the growth of the market in the region. Another important application of medical cannabis is in the treatment of neurological disorders. Research has shown that medical cannabis can be beneficial in managing symptoms of conditions such as epilepsy, multiple sclerosis, and Tourette's syndrome. With an increasing number of patients suffering from these disorders, the demand for medical cannabis is on the rise.

Cancer treatment and support is also a major area of application for medical cannabis in the Americas. The use of cannabis in cancer patients has been found to be effective in managing pain and nausea caused by chemotherapy, as well as stimulating appetite. As the number of cancer cases continues to rise, the demand for medical cannabis for these purposes is also expected to increase. Mental health is another application driving the medical cannabis market in the Americas. With the prevalence of mental health disorders, such as anxiety and depression, on the rise, patients are looking for alternative forms of treatment. Medical cannabis has been found to have positive effects on mental health, reducing anxiety and improving mood. This has resulted in a growing number of patients turning to medical cannabis for their mental health needs. In addition to these applications, medical cannabis is also being used for other purposes such as treating glaucoma, reducing inflammation, and managing symptoms of HIV/AIDS. As research into the potential medical benefits of cannabis continues to grow, we can expect to see new applications emerge, further driving the demand for medical cannabis in the Americas.

With a promising future ahead, the medical cannabis market in the region is set to continue to thrive and provide patients with much-needed relief and alternative treatment options.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.